Watson (computer)

Guerbet: 2022 revenue

Retrieved on: 
Thursday, February 9, 2023
Software, Diagnosis, Medical imaging, MRI, Iodine, Intelligence, EBITDA, CER, Guerbet, Watson (computer), Therapy, Acceleration, Pharmaceutical industry

Annual revenue in Diagnostic Imaging was up 1.7% at current exchange rates and down -2.2% at CER.

Key Points: 
  • Annual revenue in Diagnostic Imaging was up 1.7% at current exchange rates and down -2.2% at CER.
  • X-ray activity declined -4.4% at CER in 2022 due to the lower revenue from Optiray®.
  • Confirmation of the 2022 profitability target, acceleration of activity in 2023
    For 2022, despite the revenue shortfall associated with the temporary drop in production in Raleigh, Guerbet confirmed its ability to generate an EBITDA margin of between 13% and 14%, excluding extraordinary costs from the optimization of the Group’s operating structure and changes in the sales model in China.
  • Its revenue growth target for this year is above 5% on a like-for-like basis and at constant exchange rates.

Content Services Platforms (CSP) Market Size to Reach USD 176.59 Billion in 2030 | Emergen Research

Retrieved on: 
Wednesday, January 18, 2023
Music, EY, Laserfiche, Augmented reality, Kyocera, Adobe Inc., VR, CSP, IOT, Tablet, Internet, Collection, Watson (computer), Virtual reality, Organization, Marketing, Artificial intelligence, AR, Blockchain, Micro Focus, IBM, Microsoft, Book, Advertising, USD, Video game, Software, Oracle

With rise of internet penetration and growing use of mobile devices, the content services platforms market is expected to continue to grow in the coming years.

Key Points: 
  • With rise of internet penetration and growing use of mobile devices, the content services platforms market is expected to continue to grow in the coming years.
  • The revenue growth of the content service platforms (CSP) market is also driven by the increasing demand for end-to-end and cross-platform solutions.
  • Advancements in technology are a key driver for the content services platforms (CSP) market revenue growth.
  • The content services platforms market is expected to register a CAGR of 16.3% over the forecast period and revenue is projected to increase from USD 45.02 Billion in 2021 to USD 176.59 Billion in 2030.

Content Services Platforms (CSP) Market Size to Reach USD 176.59 Billion in 2030 | Emergen Research

Retrieved on: 
Wednesday, January 18, 2023
Music, EY, Laserfiche, Augmented reality, Kyocera, Adobe Inc., VR, CSP, IOT, Tablet, Internet, Collection, Watson (computer), Virtual reality, Organization, Marketing, Artificial intelligence, AR, Blockchain, Micro Focus, IBM, Microsoft, Book, Advertising, USD, Video game, Software, Oracle

With rise of internet penetration and growing use of mobile devices, the content services platforms market is expected to continue to grow in the coming years.

Key Points: 
  • With rise of internet penetration and growing use of mobile devices, the content services platforms market is expected to continue to grow in the coming years.
  • The revenue growth of the content service platforms (CSP) market is also driven by the increasing demand for end-to-end and cross-platform solutions.
  • Advancements in technology are a key driver for the content services platforms (CSP) market revenue growth.
  • The content services platforms market is expected to register a CAGR of 16.3% over the forecast period and revenue is projected to increase from USD 45.02 Billion in 2021 to USD 176.59 Billion in 2030.

Guerbet: 2023 Strategic Priorities

Retrieved on: 
Monday, January 16, 2023
Prostate cancer, European Medicines Agency, Algorithm, Face, HSG, Hysterosalpingography, Liver, X-ray, Environment, Watson (computer), Microparticle, Research, Google Images, Lymphogram, IBM Watson Health, Intellectual property, Iodine, Growth, Lipiodol, Intelligence, Liver cancer, MRI, Investment, Acquisition, EMA, Risk management, Medical imaging, Guerbet, Mer (software distribution)

Villepinte, 16 January 2023: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging has announced its strategic priorities for 2023 in a complex international environment characterised by persistent inflationary pressures and the revelation of new business opportunities for products listed in developing markets.

Key Points: 
  • Villepinte, 16 January 2023: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging has announced its strategic priorities for 2023 in a complex international environment characterised by persistent inflationary pressures and the revelation of new business opportunities for products listed in developing markets.
  • In Europe, the European Medicines Agency (EMA) review is expected in the second half of the year.
  • Guerbet also plans to divest the Occlugel technology acquired in 2018, including several ranges of microspheres for use in embolization.
  • Guerbet ultimately aims to enable the development of a major player in artificial intelligence applied to medical imaging in oncology.

S&P Global Ratings Affirms Prime Healthcare Credit Rating with a Stable Outlook

Retrieved on: 
Monday, January 9, 2023
General Health, Hospitals, Health, Hospital, MPT, EBITDA, Patient safety, Joint Commission, Medicaid, Prime Healthcare Services, Medical Properties Trust, Center for Medicare and Medicaid Innovation, Watson (computer), IBM Watson Health, Patient safety organization, Medicare, S&P Global Ratings, Health care, Health, Jewish Healthcare Foundation, Rajiv Gandhi National Quality Award, National Quality Forum, S&P, Physician, Health insurance, Healthgrades

S&P Global Ratings, in a 2022 year-end Research Update, affirmed Prime Healthcare Services's B- issuer credit rating and the B- issue-level rating on senior secured notes and issued a stable outlook.

Key Points: 
  • S&P Global Ratings, in a 2022 year-end Research Update, affirmed Prime Healthcare Services's B- issuer credit rating and the B- issue-level rating on senior secured notes and issued a stable outlook.
  • The stable outlook reflects S&P's expectations that Prime will experience an improvement of labor costs, a stabilization of patient volume trends, and continued support from state subsidy programs.
  • "Throughout the industry, increased labor costs have led to a reliance on premium labor during an unprecedented labor crisis in healthcare," said Steve Aleman, Prime Healthcare's Chief Financial Officer.
  • Prime Healthcare and Prime Healthcare Foundation comprise 45 hospitals and more than 300 outpatient locations in 14 states.

Opportunities in the Artificial Intelligence in Drug Discovery Market Investor Report: Increased R&D Productivity Drives Adoption - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 4, 2023
Health, Pharmaceutical, Algorithm, Microsoft, Element, Drug discovery, Watson (computer), IBM, Artificial intelligence, DeepMind, Deep learning, USD, Risk, Acquisition, Growth, AI, Data, Machine learning, Natural language processing, Analysis, Medical device, Pharmaceutical industry, Risk management, Retail

The "Investor Series: Opportunities in the Artificial Intelligence in Drug Discovery Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Investor Series: Opportunities in the Artificial Intelligence in Drug Discovery Market" report has been added to ResearchAndMarkets.com's offering.
  • Usually, a prescription drug requires at least 10 years to reach the market, and an average investment of over USD 2 billion.
  • In addition, it is reported that the drug discovery phase accounts for about one-third of the aforementioned costs.
  • Leveraging the abovementioned details, the report offers an informed opinion on the future outlook for investors in the AI-based Drug Discovery Market.

Opportunities in the Artificial Intelligence in Drug Discovery Market Investor Report: Lucrative Short and Long-Term Gains Available in Flourishing Sector

Retrieved on: 
Thursday, January 5, 2023
Algorithm, Microsoft, Element, Drug discovery, Watson (computer), IBM, Artificial intelligence, DeepMind, Deep learning, USD, Risk, Acquisition, Growth, AI, Data, Machine learning, Natural language processing, Analysis, Pharmaceutical industry, Medical device, Risk management, Retail

DUBLIN, Jan. 5, 2023 /PRNewswire/ -- The "Investor Series: Opportunities in the Artificial Intelligence in Drug Discovery Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 5, 2023 /PRNewswire/ -- The "Investor Series: Opportunities in the Artificial Intelligence in Drug Discovery Market" report has been added to ResearchAndMarkets.com's offering.
  • In addition, it is reported that the drug discovery phase accounts for about one-third of the aforementioned costs.
  • Taking into consideration both the historical and contemporary scenarios, we believe that the AI-based Drug Discovery Market presents lucrative investment opportunities for both short- and long-term investors.
  • Leveraging the abovementioned details, the report offers an informed opinion on the future outlook for investors in the AI-based Drug Discovery Market.

Tampa General Hospital Senior Director of Data Analytics is Nationally Recognized as a Rising Star in Health Care

Retrieved on: 
Thursday, December 22, 2022
Tampa General Hospital, Trauma, Patient, Tower, Fast Track, COVID, Home, EMR, News, Intensive care unit, Neuroscience, Partnership, COVID-19, State, Safety, IBM, Hospital, Health, Woman, U.S. News & World Report Best Hospitals Rankings, Data analysis, Hospitality Review, GE Healthcare, Richard Barker (life sciences and healthcare leader), TGH, Computer, Huang (surname), Round Top hospitals, Watson (computer), Rising Star, Software, Intelligence, Management, Pharmaceutical industry

TAMPA, Fla., Dec. 22, 2022 /PRNewswire/ -- Tampa General Hospital (TGH) Senior Director of Data Analytics, Etter Hoang, is being nationally recognized for his groundbreaking work to advance the application of health care data analytics. Becker's Hospital Review, a digital and print publication, has named Hoang to its 2022 list of Rising Stars: 104 Healthcare Leaders to Know.

Key Points: 
  • Becker's Hospital Review names Etter Hoang to its Rising Stars: 104 Healthcare Leaders to Know list for his innovative approach to data analytics and health care administration.
  • TAMPA, Fla., Dec. 22, 2022 /PRNewswire/ -- Tampa General Hospital (TGH) Senior Director of Data Analytics, Etter Hoang, is being nationally recognized for his groundbreaking work to advance the application of health care data analytics.
  • Hoang oversees the Tampa General Enterprise Analytics team as well as leads the development of enterprise vision and strategy for analytics as part of Tampa General's Data Council and Executive Analytics Steering Committee.
  • Tampa General Hospital has been designated as a model of excellence by the 2022 Fortune/Merative 100 Top Hospitals list.

Writepath Has Raised A New Round Of Investment From Elite Investor

Retrieved on: 
Monday, December 19, 2022
IR, MZ, DeepL Translator, B2B, Assistant, Advertising, Documentation, Greater, Printing, Disclosure, Marketing, Language, Reading, RR Donnelley, Richard Slator Dunn, Ecosystem, AGM, Taipei City Government, Taipei, FiscalNote, Multimedia, Directive 2014/65/EU, SDL, Soochow University, Multilingualism, United, Research, Watson (computer), AI, ESG, QIC, Security (finance), Cryptocurrency, Online shopping, Pronexus

TAIPEI, Dec. 19, 2022 /PRNewswire/ -- WritePath is proud to announce a new round of investment from prestigious investor.

Key Points: 
  • TAIPEI, Dec. 19, 2022 /PRNewswire/ -- WritePath is proud to announce a new round of investment from prestigious investor.
  • Prior to this round of fund-raising, WritePath previously received investment by UDN.com, a subsidiary of Taiwan's United Daily News Group, and well-known Singaporean translation firm Elite Asia.
  • WritePath also continues to recruit people who are passionate about language, corporate governance transparency/ESG-related regulations, and English-language information disclosure.
  • We have a wide network of contacts within local industry and in the international investment community.

AmeriHealth Caritas Appoints Neil Gomes as Senior Vice President, Chief Digital Officer; and Ngoc Trang as Senior Vice President, Chief Actuary

Retrieved on: 
Thursday, December 15, 2022
Managed Care, General Health, Health, Other Health, University, Education, Executive, Amherst College, Society, Health, Management, Goa University, Actuarial science, IE Business School, Brown University, Housing, AmeriHealth, Master of Business Administration, Multimedia, CommonSpirit Health, American Academy, AT, CHIP, Actuary, American Academy of Actuaries, Growth, Business administration, History, Food, Risk, Watson (computer), Senior, IBM, Digital, Hartford, Connecticut, Science, Medicare, Medicaid

AmeriHealth Caritas , a national leader in Medicaid managed care and other health care solutions for those most in need, announced the appointment of Neil Gomes as Senior Vice President and Chief Digital Officer; and Ngoc Trang as Senior Vice President and Chief Actuary.

Key Points: 
  • AmeriHealth Caritas , a national leader in Medicaid managed care and other health care solutions for those most in need, announced the appointment of Neil Gomes as Senior Vice President and Chief Digital Officer; and Ngoc Trang as Senior Vice President and Chief Actuary.
  • Gomes will report to Paul A. Tufano, Chairman and CEO of AmeriHealth Caritas.
  • Trang will report to Bob Kolodgy, Executive Vice President & Chief Financial Officer.
  • Trang joins AmeriHealth Caritas with a background in finance, underwriting and actuary built over a career spanning nearly two decades.